期刊文献+

THAP11通过抑制p53的泛素化影响食管癌细胞的增殖和凋亡 被引量:2

THAP11 mediates the proliferation and apoptosis of esophageal cancer cells via inhibiting ubiquitination of p53
下载PDF
导出
摘要 目的:探讨死亡相关蛋白(thanatos-associated protein,THAP)11对食管癌细胞增殖和凋亡的影响及其潜在的机制。方法:采用蛋白质印迹法检测人食管上皮细胞Het-1A和人食管癌细胞(Eca109,TE-1和Ec 9706)中THAP11的表达。将食管癌TE-1细胞分为空白对照(NC)组、阴性对照(LV-LC)组、TRAP11(LV-TRAP11)组,按分组处理细胞后,采用MTT法检测细胞活力,流式细胞术检测细胞凋亡,caspases试剂盒检测caspase-3和caspase-9的活性。采用体外泛素化实验检测TE-1细胞的p53泛素化水平。结果:与Het-1A细胞相比,食管癌细胞中THAP11的表达显著下降(P<0.05)。LV-THAP11转染食管癌细胞后,细胞活力降低(P<0.05),凋亡率升高(P<0.05),caspase-3和caspase-9活性升高(P<0.05)。THAP11能够提高食管癌细胞中p53蛋白的表达(P<0.05)。与LV-LC组相比,转染THAP11后食管癌细胞中p53的表达上调(P<0.05),MDM2调节的p53的泛素化也被抑制。结论:THAP11通过抑制p53的泛素化抑制食管癌细胞的增殖,促进食管癌细胞的凋亡。 Objective:To investigate the effects of thanatos-associated protein 11 (THAP11) on the proliferation and apoptosis of esophageal cancer cell and the underlying mechanism.Methods:Expression of THAP11 in human esophageal epithelial cells (Het-1A) and esophageal cancer cells (Eca109,TE-1,Ec 9706) were detected by Western blotting.Esophageal cancer TE-1 cells were divided into 3 groups:a normal control (NC) group,a negative control (LV-NC) group and a THAP11 (LV-THAP11) group.Then the cell proliferation were detected by MTT assay,cell apoptosis were detected by flow cytometry,caspase-3 and caspase-9 levels were detected by caspases kits.Ubiquitination of p53 was determined in esophageal cancer TE-1 cells.Results:Expression of THAP11 was reduced in esophageal cancer cells compared with human esophageal epithelial cells (P<0.05).After transfection with LV-THAP11 in TE-1 cells,cell viability was reduced (P<0.05),while apoptosis rate and caspase-3 and caspase-9 levels were increased (P<0.05),indicating that THAP11 inhibited growth of esophageal cancer cells.In addition,the THAP11 increased the levels of p53 (P<0.05) and inhibited the ubiquitination of p53 regulated by MDM2.Conclusion:THAP11 may inhibit the proliferation of esophageal cancer cells by inhibiting ubiquitination of p53.
作者 金迎迎 王宝峰 柯悦 李毅 李芳 罗恒 孟鑫 崔新悦 JIN Yingying;WANG Baofeng;KE Yue;LI Yi;LI Fang;LUO Heng;MENG Xin;CUI Xinyue(Department of Oncological Radiotherapy,Second Hospital Affi liated to Xi'an Jiaotong University,Xi’an 710004,China)
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2019年第12期1338-1343,共6页 Journal of Central South University :Medical Science
关键词 死亡相关蛋白11 P53 泛素化 食管癌 thanatos-associated protein 11 p53 ubiquitination esophageal cancer
  • 相关文献

参考文献1

二级参考文献16

  • 1于静萍,孙志强,倪新初,王坚,李毅,胡莉钧,李栋庆,孙苏平.食管癌患者放疗前后血清血管内皮生长因子变化的临床意义[J].中华放射医学与防护杂志,2011,31(6). 被引量:12
  • 2汲振余,赵立群,杨观瑞,索振河,JahnM.Nesland,彭迁.HIF-1α在食管上皮细胞中的诱导表达及对光动力疗法的影响[J].肿瘤,2006,26(6):507-511. 被引量:3
  • 3Karamouzis, MV, Moschos SJ. The use of endostatin in the treatment of solid tumors. Expert Opin Bioi Ther, 2009, 9 (5) : 641-648.
  • 4Semenza GL. HIF -1 and mechanisms of hypoxia sensing. Curr Opin Cell Bioi, 2001, 13 (2) : 167 -171.
  • 5Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch, 2005, 450 (6) : 363 -371.
  • 6Hanna NN, Seetharam S, Mauceri HJ, et al. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer, 2000, 6 (5) : 287 -293.
  • 7Itasaka S, Komaki R, Herbst RS, et al. Endostatin improves radioresponse and blocks tumor revascularization after therapy for A431 xenografts in mice. IntJ Radiat Oncol Bioi Phys, 2007, 67 (3) :870-878.
  • 8Yoon MS, Nam TK, LeeJS, et al. VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.J Korean Med Sci, 2011, 26(4) :513-520.
  • 9Takala H, Saarnio 1. Wiik H, et al. HIF -1 a and VEGF are associated with disease progression in esophageal carcinoma.J Surg Res, 2011, 167(1) :41-48.
  • 10Tzao C, Lee SC, Tung HJ, et al. Expression of hypoxia?inducible factor (HIF) -1 a and vascular endothelial growth factor ( VEGF ) -D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers, 2008, 25 ( 3 ) : 141-148.

共引文献9

同被引文献4

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部